MiR-145 alleviates Hcy-induced VSMC proliferation, migration, and phenotypic switch through repression of the PI3K/Akt/mTOR pathway
- 2 March 2020
- journal article
- research article
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 153 (5) , 357-366
Abstract
The proliferation, migration, and cellular morphology of vascular smooth muscle cells (VSMCs) play important roles in the pathogenesis of atherosclerosis (AS). Homocysteine (Hcy) is a sulfur-containing amino acid, which is an intermediate product of methionine metabolism. Hcy can induce proliferation, migration, and phenotypic switch of VSMCs, but details of these mechanisms are still unclear. The phosphatidylinositol 3-kinase (PI3K/Akt/mTOR) signaling pathway is involved in a host of cellular functions. In this study, we sought to determine if this multifunctional pathway played a role in Hcy-induced proliferation, migration, and phenotypic transformation of VSMCs, which has not been previously reported. miR-145 has been previously reported to suppress the effects of Hcy in VSMCs. In our study, using qRT-PCR, we found that Hcy itself reduced the expression of miR-145 in VSMCs, while overexpression of miR-145 reduced the proliferation, migration, and phenotypic transformation of VSMCs caused by Hcy. Using Western blot analysis, we found that VSMCs exposed to Hcy exhibited significant increases in the levels of PI3K, Akt, and mTOR proteins. Additionally, overexpression of miR-145 dramatically decreased PI3K, Akt, and mTOR expression. Using qRT-PCR we found that miR-145 expression increased after blocking PI3K using an inhibitor. Inhibition of the PI3K signaling pathway also prevented Hcy-induced VSMC proliferation, migration, and phenotypic switch. Taken together, our results suggest that miR-145 could inhibit VSMC proliferation, migration, and phenotype switching by preventing activation of the PI3K/Akt/mTOR signaling pathway.Keywords
Funding Information
- Ningxia High School first-class Discipline (NXYLXK2017B07)
- Natural Science Foundation of Ningxia Province (2019AAC03081)
- National Natural Science Foundation of China (No. 81770459, No. 81970369)
This publication has 29 references indexed in Scilit:
- MicroRNA-145 Restores Contractile Vascular Smooth Muscle Phenotype and Coronary Collateral Growth in the Metabolic SyndromeArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- The lysosomal transfer of LDL/cholesterol from macrophages into vascular smooth muscle cells induces their phenotypic alterationCardiovascular Research, 2012
- Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cellsJournal of Molecular and Cellular Cardiology, 2012
- MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion FormationCirculation Research, 2009
- miR-145 and miR-143 regulate smooth muscle cell fate and plasticityNature, 2009
- A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancerCancer, 2009
- MicroRNomics: a newly emerging approach for disease biologyPhysiological Genomics, 2008
- MicroRNA Expression Signature and Antisense-Mediated Depletion Reveal an Essential Role of MicroRNA in Vascular Neointimal Lesion FormationCirculation Research, 2007
- MicroRNAs and the regulation of cell deathTrends in Genetics, 2004
- MicroRNAs Modulate Hematopoietic Lineage DifferentiationScience, 2004